Tricaprin is a medium-chain triglyceride (MCT) made up of three capric acid (C10) chains attached to a glycerol backbone, and it shows up naturally in a handful of common foods. Coconut oil is the most familiar dietary source, though it contains only a small percentage. Most people encounter tricaprin indirectly through MCT oil supplements or through dairy fat, palm kernel oil, and coconut products. The compound has drawn research attention for effects that go well beyond simple calories, from heart disease treatment to cognitive protection through a mechanism distinct from the better-known C8 triglyceride.
Where Tricaprin Occurs Naturally
Coconut oil is probably the most widely available whole-food source of tricaprin, but the amount is modest. In a study comparing the ketone-raising effects of various MCT oils, researchers noted that coconut oil contained roughly 5% tricaprin (C10) alongside about 3% tricaprylin (C8), with the bulk of its fat coming from lauric acid (C12) and longer chains.1PubMed Central. Tricaprylin Alone Increases Plasma Ketone Response More Than Coconut Oil or Other Medium-Chain Triglycerides: An Acute Crossover Study in Healthy Adults That means a tablespoon of coconut oil delivers only a fraction of a gram of tricaprin. Palm kernel oil has a similar fatty acid profile and contributes comparable amounts. Butter and other full-fat dairy products contain traces of capric acid as well, though the concentrations are even lower than in coconut oil.
To get a meaningful dose of tricaprin from whole foods alone, you would need to consume impractical quantities of coconut oil or butter. This is why concentrated MCT oils exist. A standard commercial MCT oil blend typically contains roughly 55% C8 and 35% C10 by weight, making it a far richer source of tricaprin than any unprocessed food.2PubMed Central. Tricaprylin Alone Increases Plasma Ketone Response More Than Coconut Oil or Other Medium-Chain Triglycerides: An Acute Crossover Study in Healthy Adults Some specialty products are marketed as “C10 oil” and contain over 95% tricaprin, though these are less common than C8-dominant oils.
How Your Body Handles Tricaprin
Medium-chain triglycerides like tricaprin follow a digestive shortcut that longer-chain fats do not. Once consumed, they are broken down relatively quickly, and the released medium-chain fatty acids travel directly to the liver through the portal vein rather than being packaged into the large lipoprotein particles that carry longer-chain fats through the lymphatic system.3Scientific Reports. Medium-chain triglycerides tricaprin TC10 and tricaprylin TC8 attenuated HFD-induced cognitive decline in a manner dependent on or independent of GLP-1 This direct liver route means the body can use the energy from tricaprin faster than it can from, say, olive oil or beef fat.
Even the stomach begins working on tricaprin before pancreatic enzymes get involved. Early research on human gastric lipase found that the enzyme’s optimal pH shifts depending on the fat’s chain length. For tricaprin, that optimum was around pH 7.2, compared to 7.9 for tristearin, a long-chain saturated fat.4Acta Physiologica Scandinavica. The Gastric Lipase in Man The practical takeaway is that the stomach environment is better matched for breaking down medium-chain fats like tricaprin than it is for the long-chain fats that dominate most Western diets. That said, the speed of transport to the liver still depends on chain length even among MCTs, with shorter chains generally moving faster.
Tricaprin Versus Tricaprylin and the Ketone Question
One of the more interesting findings in MCT research is that tricaprin (C10) and tricaprylin (C8) do not behave the same way in the body, despite both being classified as medium-chain triglycerides. The most obvious difference involves ketone production. C8 is a powerful ketone generator: it reliably raises blood levels of beta-hydroxybutyrate, the ketone body that the brain and muscles can use as fuel. Tricaprin does not do this to any meaningful degree. In a controlled study, C8 administration significantly increased blood ketone concentrations in mice, while C10 did not.5PubMed Central. Medium-chain triglycerides tricaprin TC10 and tricaprylin TC8 attenuated HFD-induced cognitive decline in a manner dependent on or independent of GLP-1 Human data point in the same direction: a study measuring ketogenesis after different MCT interventions found that the ketone-raising effect decreased as chain length increased.6PubMed Central. Short-Term Influence of Caffeine and Medium-Chain Triglycerides on Ketogenesis: A Controlled Double-Blind Intervention Study
If you are buying MCT oil primarily to boost ketones, whether for a ketogenic diet or for the cognitive effects associated with elevated ketone levels, pure C8 oil is the more efficient choice. But that does not mean tricaprin is inert. It appears to work through a completely different pathway, which brings us to its effects on the brain.
Cognitive Benefits Through a Different Pathway
Researchers studying mice on a high-fat diet found that both tricaprylin (C8) and tricaprin (C10) protected against cognitive decline, but through distinct mechanisms. C8 did its work largely by raising ketone levels and supporting mitochondrial function in the hippocampus, the brain region central to memory. Tricaprin, on the other hand, increased blood levels of GLP-1, a hormone better known for its role in blood sugar control and appetite regulation. When the researchers blocked the GLP-1 receptor with an antagonist drug, the cognitive benefits of tricaprin disappeared, confirming that GLP-1 signaling was the key mechanism.7PubMed Central. Medium-chain triglycerides tricaprin TC10 and tricaprylin TC8 attenuated HFD-induced cognitive decline in a manner dependent on or independent of GLP-1
Further investigation showed that the active molecule was not intact tricaprin itself, but rather 2-monocaprin, a partially digested form. In cell experiments, 2-monocaprin stimulated GLP-1 secretion and decreased intracellular cAMP concentrations.8PubMed Central. Medium-chain triglycerides tricaprin TC10 and tricaprylin TC8 attenuated HFD-induced cognitive decline in a manner dependent on or independent of GLP-1 This is a genuinely novel finding. GLP-1 receptor agonists are already blockbuster drugs for diabetes and obesity, so the idea that a dietary fat could nudge the same pathway, even modestly, has attracted attention. This research is still early-stage and conducted in animals, so nobody should treat coconut oil as a substitute for prescribed GLP-1 drugs. But the mechanism is plausible and specific enough to warrant continued study.
The implication for people choosing between C8 and C10 supplements is that the two may be complementary rather than interchangeable. C8 feeds the brain through ketones. C10 may support cognition through a hormonal route that has nothing to do with ketones. A blended MCT oil containing both could, in theory, activate both pathways, though human trials testing that combination for cognitive outcomes have not yet been published.
Epilepsy and Seizure Management
The ketogenic diet has been used to manage epilepsy for about a century, and MCT oils have been part of modified versions of that diet since the 1970s. More recent evidence suggests that the medium-chain fatty acids released from MCT oils, particularly decanoic acid (the fatty acid released from tricaprin), may have direct anticonvulsant effects beyond simply producing ketones. A review of data from rodent seizure models, dogs with epilepsy, and human patients found that MCT supplementation was tolerated by roughly 65% of human participants and showed efficacy in dog studies, with possible anticonvulsant and antioxidant mechanisms attributed specifically to decanoic acid.9PubMed Central. Dietary medium chain triglycerides for management of epilepsy: New data from human, dog, and rodent studies
This is worth noting because it suggests tricaprin’s value in epilepsy management may not rest entirely on ketone production, which, as described above, is modest for C10 compared to C8. The decanoic acid itself appears to interact with neuronal receptors in ways that reduce seizure susceptibility. For patients or caregivers exploring MCT-supplemented ketogenic diets, this means that a C10-containing oil could provide benefits that a pure C8 oil might not, even if the C8 version produces more ketones.
An Orphan Drug for a Rare Heart Disease
Perhaps the most dramatic application of tricaprin in medicine has nothing to do with diet. Researchers in Japan identified a rare condition called triglyceride deposit cardiomyovasculopathy (TGCV), in which triglycerides accumulate in the heart muscle and blood vessel walls because the cells lack the ability to properly break them down. The disease leads to progressive heart failure and coronary artery disease. Tricaprin, administered as a pharmaceutical preparation called CNT-01, emerged as a potential treatment because it can facilitate the breakdown of those trapped triglycerides.
In a small clinical study using a nuclear imaging technique to measure fat metabolism in the heart, patients who received CNT-01 showed a statistically significant improvement in myocardial fat breakdown compared to the placebo group. The difference in the imaging marker between the two groups was significant at p=0.035.10Annals of Nuclear Cardiology. 123I-BMIPP Scintigraphy Shows That CNT-01 (Tricaprin) Improves Myocardial Lipolysis in Patients with Idiopathic Triglyceride Deposit Cardiomyovasculopathy Longer-term registry data reported remarkable survival and durable recovery of heart failure in TGCV patients treated with supplemental tricaprin.11PubMed. Long-term survival and durable recovery of heart failure in patients with triglyceride deposit cardiomyovasculopathy treated with tricaprin A phase IIb/III clinical trial with tricaprin as a first-in-class orphan drug is underway in Japan.12Oxford Academic (ESC Heart Failure). Distinct Myocardial Triglyceride Lipolysis Pathways in Primary and Idiopathic Triglyceride Deposit Cardiomyovasculopathy
TGCV is rare enough that most people will never encounter it, but this line of research is a useful reminder that a single compound can have entirely different applications depending on context. The tricaprin in your MCT oil and the tricaprin being tested as a heart drug are chemically identical. The difference is dosing, delivery, and the specific metabolic problem being addressed.
Effects on Cholesterol and Body Fat
Animal studies have consistently shown that medium-chain fats behave differently from long-chain fats when it comes to blood lipids. In a rat feeding study, animals given tricaprin had notably lower serum cholesterol, in the range of 43 to 49 mg/dL, compared to rats fed longer-chain fats like tripalmitin or tristearin, which showed levels of 54 to 59 mg/dL.13The Journal of Nutrition. Effects of Dietary Triglycerides on Serum and Liver Lipids and Sterol Excretion of Rats That is a meaningful gap in animals, though translating rat lipid numbers directly to human cardiovascular risk is always uncertain.
The broader MCT literature also supports modest metabolic advantages. Replacing long-chain fats with MCTs in the diet has been shown to increase energy expenditure, reduce food intake, and decrease body fat mass in both animal and human studies, without adversely affecting blood lipid profiles.14Journal of Nutritional Oncology. Application of medium-chain fatty acids in metabolic diseases The thermogenic effect, meaning MCTs slightly increase the number of calories your body burns as heat, is real but small. Nobody should expect MCT oil to replace exercise or caloric control, but swapping some long-chain cooking fat for an MCT-containing oil is unlikely to worsen your metabolic profile and might offer a slight edge.
Tricaprin in Infant Nutrition
Capric acid and its triglyceride form are naturally present in human breast milk, which raises the question of what role they play in infant gut health. Research examining various lipids found in human milk found that while free fatty acids and monoglycerides (partially broken-down fats) tended to inhibit the growth of beneficial Bifidobacteria, intact triglycerides did not. In fact, some triglycerides actually enhanced the growth of these beneficial bacteria.15J-STAGE / The Journal of General and Applied Microbiology. Effect of Various Lipids Found in Human Milk on the Growth of Infant Bifidobacteria Meanwhile, harmful gram-negative bacteria like E. coli and Salmonella were more resistant to the antimicrobial effects of the free fatty acids and monoglycerides.
The picture that emerges is that breast milk fat performs a double duty: in its intact triglyceride form, it nourishes beneficial gut bacteria, and once lipases partially break it down into free fatty acids and monoglycerides, those breakdown products help suppress harmful bacteria. Tricaprin, as one of the triglycerides present in breast milk, likely participates in this balance, though its specific contribution relative to other milk triglycerides is hard to isolate.
Food Science and Physical Properties
Outside of nutrition, tricaprin has caught the attention of food scientists for an unusual physical property: it can spontaneously form a powder at room temperature and then mix with water to create a stable paste. Researchers found that when spontaneously powdered tricaprin crystals were mixed with water at a 4:6 powder-to-water ratio, the resulting paste remained stable for several days without separating. At a 3:7 ratio, the mixture formed a non-flowing paste with no visible free water. Commercial MCT powders, which typically require added excipients like maltodextrin to hold their structure, behaved quite differently, dispersing into a thin suspension rather than forming a paste.16npj Science of Food. Spontaneous granulation of tricaprin and trilaurin medium-chain triacylglycerols with added medium- and long-chain species
This matters for the food industry because creating stable fat-water mixtures without emulsifiers or bulking agents is valuable for clean-label products. A tricaprin-based powder that thickens into a paste when mixed with water could serve as a fat replacer or texture modifier in foods where consumers want fewer additives. The technology is early, but it hints at applications in protein bars, meal-replacement shakes, and baked goods where a stable, additive-free fat component is desirable.
How Tricaprin Is Manufactured
The tricaprin found in supplements and used in research is not typically extracted from coconut oil. At only 5% of coconut oil’s fat profile, extraction would be inefficient. Instead, it is usually synthesized by combining glycerol with capric acid in the presence of an enzyme catalyst. Researchers have demonstrated production of tricaprin using an immobilized lipase enzyme in a solvent-free system, achieving appreciable yields at around 70°C with an enzyme concentration of 5 to 9% by weight.17PubMed. Enzymatic synthesis of medium-chain triglycerides in a solvent-free system The solvent-free approach is attractive for food-grade production because it avoids the residual solvents that complicate other synthesis methods.
For consumers, the manufacturing method does not change the molecule’s identity or effects. Tricaprin synthesized enzymatically is chemically identical to tricaprin found in coconut oil. But understanding the production route explains why pure C10 supplements can exist at all, given how dilute the compound is in natural food sources. It also explains the price difference: purified tricaprin costs more than standard MCT oil blends because the isolation and enzymatic synthesis steps add complexity.
Safety and Digestive Tolerance
MCTs as a class have a strong safety record. The most common side effects are gastrointestinal: nausea, loose stools, and stomach discomfort, especially when taken on an empty stomach or in large doses. Starting with a small amount, half a teaspoon to a teaspoon, and gradually increasing over a week or two is the standard advice for anyone new to MCT oils. Tricaprin does not appear to carry any unique risks beyond those shared by MCTs generally.
One practical consideration is that because tricaprin does not spike ketone levels the way C8 does, people using it specifically for a ketogenic protocol might assume it is not “working” and increase the dose aggressively. This is a recipe for GI distress. The benefits of tricaprin, whether through GLP-1 signaling, metabolic effects, or direct action of decanoic acid, do not require the high ketone readings that C8 oil produces. Judging tricaprin’s effectiveness by a ketone meter reading misunderstands how it works and can lead to unnecessary overconsumption. Patience with gradual dose increases and realistic expectations about what C10 does differently from C8 will make for a better experience.